HealthLynked Corp. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-03-31 was $4.06M, a 522.40% increase year-over-year.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-09-30 was $479.67K, a 653.50% increase year-over-year.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $533.28K, a 284.31% increase year-over-year.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $652.56K, a 21.92% increase year-over-year.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $4.06M, a 143.86% increase from fiscal 2020.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $1.67M, a 36.57% increase from fiscal 2019.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $1.22M, a 2789.19% increase from fiscal 2018.
- HealthLynked Corp. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $42.21K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2021-12-31 | $4.06M 10-K · filed 2023-03-31 | |
| 2021-03-31 | $4.06M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $1.67M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $479.67K 10-Q · filed 2021-11-15 | $2.15M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $533.28K 10-Q · filed 2021-11-15 | $1.73M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-03-31 | $652.56K 10-Q · filed 2021-11-15 | $1.34M derived: sum of 4 quarters · filed 2021-11-15 |
| 2019-12-31 | $481.90K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.22M 10-K · filed 2021-03-31 |
| 2019-09-30 | $63.66K 10-Q · filed 2020-11-16 | $731.36K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $138.76K 10-Q · filed 2020-11-16 | $716.20K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-03-31 | $535.23K 10-Q · filed 2020-11-16 | |
| 2018-12-31 | -$6.29K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $42.21K 10-K · filed 2020-03-30 |
| 2018-09-30 | $48.50K 10-Q · filed 2019-11-14 |